Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 5, 2009, Pages 1281-1285

  Oda, Jun ^a,b   Kasai, Kosuke ^b   Noborio, Mitsuhiro ^b   Aoki, Yoshiki ^b   Yamashita, Katsuyuki ^b   Inoue, Takuya ^b   Ueyama, Masashi ^b   Yukioka, Tetsuo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b CHUKYO HOSPITAL   (Japan)

Author keywords

Acute renal failure; Burns; Diuretic phase; Human atrial natriuretic peptide; Sodium excretion

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; CREATININE; FUROSEMIDE; SODIUM; WATER;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; BURN SHOCK; CARDIOVASCULAR DISEASE; CENTRAL VENOUS PRESSURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; DRUG INTERMITTENT THERAPY; FEMALE; FLUID RESUSCITATION; FREE WATER CLEARANCE; HEART RATE; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG DISEASE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OXYGENATION; PRIORITY JOURNAL; SENESCENCE; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINE VOLUME; VITAL SIGN; AGE; BREATHING MECHANICS; BURN; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; INJURY SCALE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY FUNCTION TEST; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PROBABILITY; RISK ASSESSMENT; SURVIVAL; TRAUMATIC SHOCK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BLOOD GAS ANALYSIS; BURN UNITS; BURNS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INJURY SEVERITY SCORE; KIDNEY; KIDNEY FUNCTION TESTS; LUNG; MALE; MIDDLE AGED; PROBABILITY; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS; RISK ASSESSMENT; SHOCK, TRAUMATIC; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 67649647739     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31819dc47e     Document Type: Article

References (31)

1. Aikawa N, Wakabayashi G, Ueda M, Shinozawa Y. Regulation of renal function in thermal injury. J Trauma. 1990;30:S174-S178.
2. Schiavon M, Di Landro D, Baldo M, De Silvestro G, Chiarelli A. A study of renal damage in seriously burned patients. Burns Incl Therm Inj. 1988;14:107-112.
3. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990; 70:665-699.
4. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature. 1986;324: 473-476.
5. Conger JD, Falk SA, Yuan BH, Schrier RW. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int. 1989;35:1126-1132.
6. Nakamoto M, Shapiro JI, Shanley PF, Chan L, Schrier RW. In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest. 1987;80:698-705.
7. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 1994;45:1731- 1738.
8. Valsson F, Ricksten SE, Hedner T, Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med. 1996;22:230-236.
9. Swärd K, Valson F, Ricksten SE. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand. 2001;45:536-542.
10. Swärd K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31:79-85.
11. Monafo WW. The treatment of burn shock by the intravenous and oral administration of hypertonic lactated saline solution. J Trauma. 1970;10:575-586.
12. Shimazaki S, Yoshioka T, Tanaka N, Sugimoto T, Onji Y. Body fluid changes during hypertonic lactated saline solution therapy for burn shock. J Trauma. 1977;17:38-43.
13. Oda J, Yamashita K, Inoue T, et al. Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns. 2006;32:151-154.
14. Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007;9:60-68.
15. Graves TA, Cioffi WG, Vaughan GM, et al. The renal effects of low-dose dopamine in thermally injured patients. J Trauma. 1993; 35:97-103.
16. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low- dose dopamine in patients with early renal dysfunction: a placebo- controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356: 2139-2143.
17. Ledsome JR, Wilson N, Courneya CA, Rankin AJ. Release of atrial natriuretic peptide by atrial distension. Can J Physiol Pharmacol. 1985;63:739-742. ;
18. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.
19. Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy. Circ J. 2005;69: 283-290.
20. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002;144:1102-1108.
21. Braquet M, Carsin H, Guilbaud J, Chabrier E, Viossat I, Braquet P. Plasma atrial natriuretic peptide in severe thermal injury. Lancet. 1986;23:456.
22. Wakabayashi G, Ueda M, Aikawa N, Abe O. Atrial natriuretic polypeptide after burn injury: blood levels and physiological role in rats. Burns. 1990;16:169-175.
23. Cioffi WG Jr, Vaughan GM, Heironimus JD, Jordan BS, Mason AD Jr, Pruitt BA Jr. Dissociation of blood volume and flow in regulation of salt and water balance in burn patients. Ann Surg. 1991;214:213- 220.
24. Onuoha GN, Alpar EK, Gowar J. Plasma levels of atrial natriuretic peptide in severe burn injury. Burns. 2000;26:449-453.
25. Sakurai H, Nozaki M, Traber KS, Traber DL. Atrial natriuretic peptide release associated with smoke inhalation and physiological responses to thermal injury in sheep. Burns. 2005;31:737-743.
26. Shirani KZ, Vaughan GM, Robertson GL, et al. Inappropriate vasopressin secretion (SIADH) in burned patients. J Trauma. 1983; 23:217-224.
27. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985; 313:1330-1340.
28. Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Trauma. 1992;33:45-48.
29. Hutchens MP, Weinmann M. Renal protection with recombinant b-type natriuretic peptide in a burn patient with rhabdomyolysis. Burns. 2006;32:128-131.
30. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487-1491.
31. Mitaka C, Hirata Y, Habuka K, et al. Atrial natriuretic peptide improves pulmonary gas exchange by reducing extravascular lung water in canine model with oleic acid-induced pulmonary edema. Crit Care Med. 2002;30:1570-1575.